E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/11/2006 in the Prospect News Biotech Daily.

Invitrogen, Human Proteome Organization enter protein research partnership

By Elaine Rigoli

Tampa, Fla., July 11 - Invitrogen Corp. and the Human Proteome Organization (HUPO) have entered into a scientific collaboration focused on advancing proteomic research through education initiatives, standardization of research protocols and development of advanced proteomic products.

Under the collaboration, Invitrogen scientists will support efforts driven by HUPO and its members internationally to develop new proteomic standards, products and processes.

Invitrogen will also support a number of global educational programs and resources.

Financial terms of the collaboration were not disclosed.

"Our partnership with HUPO enables our researchers to work closely with thought leaders in the field of proteomics. By improving education, training and technology development, our organization can provide scientists the ability to better understand critically important areas of research," chairman and chief executive officer Gregory T. Lucier said in a news release.

Invitrogen is a Carlsbad, Calif.-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.